Fertility and IVF: Clinics, Costs, Egg Freezing and the Law — 2026-09-12

Top developments

WIRED Investigates Cofertility’s "Freeze & Share" Model

In a feature published on September 9, 2026, WIRED examined the ethical and financial implications of Cofertility’s "Keep" program, which offers free egg freezing in exchange for sharing half the retrieved eggs with other patients. The article highlights growing scrutiny regarding the long-term legal and emotional complexities of this shared-risk model, particularly as more young women seek fertility preservation without insurance coverage. This development is critical for understanding the emerging business models in US fertility care, where high out-of-pocket costs (often exceeding $14,000 per cycle) drive innovation in financing structures.

Gyeonggi Province Redirects Funds from Postpartum Care to Infertility Support

On September 9, 2026, South Korea’s Gyeonggi Province announced it will terminate its 500,000 KRW ($370) postpartum recovery subsidy on September 30, 2026, to reallocate approximately 95.6 billion KRW ($70 million) toward expanding infertility treatment support. This move reflects a strategic pivot in Korean demographic policy, prioritizing assisted reproductive technology (ART) access for struggling couples over universal postpartum cash handouts. The province aims to remove income-based restrictions for certain ART subsidies, potentially increasing cycle volumes and reducing financial barriers for thousands of couples.

ESHRE Releases First New Lab Standards in 11 Years

The European Society of Human Reproduction and Embryology (ESHRE) announced new guidelines for IVF laboratory practices, marking the first major update to these standards in over a decade. As reported by local Korean media on September 7, 2026, these new standards aim to standardize embryo culture conditions and quality assessment protocols globally. For patients and clinics, this could lead to more consistent IVF success rates and reduced variability between labs, addressing a key criticism of ART outcomes where "invisible" lab conditions significantly impact live birth rates.

Gangneung City Launches "Gangneung-Type" Extra Fertility Subsidies

On September 7, 2026, Gangneung City in Gangwon Province launched a new initiative to provide up to five additional cycles of subsidized fertility treatment for couples who have exhausted national government limits. This local-level expansion addresses the gap where national insurance coverage ends but treatment is still medically recommended. It signals a trend of municipalities in South Korea taking independent action to boost fertility rates, potentially serving as a model for other cities facing similar demographic crises.

Local view

South Korea: Local media outlets like Rapportian and Yongin Ilbo are focusing heavily on the technical aspects of IVF success, such as uterine receptivity testing for repeated implantation failures and the new ESHRE lab standards. Rapportian notes that while diagnosis rates have risen 31% since 2020 to over 300,000 individuals, the focus is shifting from mere access to optimizing clinical protocols for those experiencing repeated failures.

Japan: While no major national policy shifts occurred this week, Japanese media continues to highlight the impact of Tokyo's 150,000 yen subsidy for infertility treatments introduced earlier this year. Articles from Yahoo! News Japan featuring experts from the University of Tokyo emphasize that despite insurance coverage making treatment more accessible, many couples still face high out-of-pocket costs for advanced procedures not fully covered, maintaining pressure on local clinics to offer transparent pricing.

Context & numbers

• US Egg Freezing Costs: The average cost for one egg freezing cycle in the US remains high, with recent data citing averages around $14,364, though this varies significantly by clinic and region. New employer benefits and drug discounts are slowly altering these figures.
• Employer Insurance Market Growth: The market for employer fertility stop-loss insurance is projected to reach $2.48 billion by 2030, driven by companies seeking to manage the rising costs of employee fertility benefits. This trend suggests a growing corporate interest in stabilizing healthcare costs related to ART.
• Korean Infertility Diagnosis Rates: According to National Health Insurance Service data cited in Korean reports, the number of people diagnosed with infertility reached 304,010 in 2024, a 31% increase from 2020 levels, underscoring the urgency of the subsidy expansions seen in Gyeonggi and Gangneung.

On the radar

• Gyeonggi Subsidy Deadline: Couples in Gyeonggi Province must apply for the current postpartum subsidy by September 30, 2026, before the funds are fully redirected to infertility programs.
• Cofertility Legal Scrutiny: Following the WIRED report, watch for potential regulatory inquiries or class-action lawsuits regarding the transparency of the "Freeze & Share" contract terms.